The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trodelvy use in advanced triple negative breast cancer in Australia (TRACIE): Study design and interim analysis.
 
Vanessa Wong
Speakers' Bureau - Amgen; Novartis
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
 
Grace Kim
No Relationships to Disclose
 
Yoland Antill
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; MSD Oncology
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Pfizer
Speakers' Bureau - MSD Oncology
Research Funding - AstraZeneca
Expert Testimony - AstraZeneca
 
Sally Baron-Hay
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; Merck Sharpe and Doehme; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; MSD Oncology; Novartis
Travel, Accommodations, Expenses - Gilead Sciences; Gilead Sciences; MSD Oncology; Novartis
 
Frances Boyle
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
 
Kerry Cheong
Travel, Accommodations, Expenses - AstraZeneca; Merck
 
Katharine Cuff
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; MSD; Novartis
Speakers' Bureau - AstraZeneca; Gilead Sciences; MSD; Novartis
 
Rachel Dear
No Relationships to Disclose
 
Richard De Boer
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Novartis
 
Abhishek Joshi
Honoraria - Ipsen
Consulting or Advisory Role - Amgen; Merck Sharp & Dohme; Roche
Speakers' Bureau - Merck; Novartis; Roche
 
Sanjeev Kumar
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
 
Louise Nott
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Ipsen; Merck; MSD; Novartis; Pfizer; Roche; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; MSD; Pierre Fabre; Roche
Research Funding - Roche; SERVIER
 
Gaik Tin Quah
No Relationships to Disclose
 
Iris Tung
No Relationships to Disclose
 
Meng Wang
Employment - Gilead Sciences
 
Michelle White
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology
Speakers' Bureau - AstraZeneca; Gilead Sciences; MSD Oncology
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Shane White
Speakers' Bureau - AstraZeneca; Lilly; Novartis
 
Belinda Yeo
Honoraria - AstraZeneca; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Gilead Sciences
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche
 
Nicholas Zdenkowski
Honoraria - AstraZeneca; Eisai; Gilead Sciences; Lilly; Menarini; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; MSD; Novartis; Roche
Research Funding - Lilly (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; Novartis; Pfizer; Roche
 
Sheau Wen Lok
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); MSD (Inst); Novartis (Inst)